Cynvec Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.4M

  • Investors
  • 4

Cynvec General Information

Description

Developer of a viral immunotherapeutic designed to employ patients' immune systems to improve clinical outcomes over a diverse range of cancers. The company's biotechnology agents specialize in targeting tumor cells throughout the body and activating patients' immune systems to eradicate the cancerous cells, enabling healthcare organizations to cure or treat cancer patients.

Contact Information

Website
www.cynvec.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 120 West 45th Street
  • Suite 3600
  • New York, NY 10036
  • United States
+1 (914)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 120 West 45th Street
  • Suite 3600
  • New York, NY 10036
  • United States
+1 (914)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cynvec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2021 $2.4M Completed Pre-Clinical Trials
6. Grant 09-Jul-2020 Completed Pre-Clinical Trials
5. Angel (individual) 15-Aug-2017 Cancelled Pre-Clinical Trials
4. Grant 01-Jan-2016 Completed Pre-Clinical Trials
3. Seed Round 07-Dec-2015 Completed Pre-Clinical Trials
2. Angel (individual) 18-Mar-2009 $500K $5.5M Completed Pre-Clinical Trials
1. Angel (individual) 28-Nov-2006 $5M $5M Completed Pre-Clinical Trials
To view Cynvec’s complete valuation and funding history, request access »

Cynvec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cynvec Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
National Cancer Institute Government
Alexander 2006 Corporation Minority
The Litwin Foundation Other Minority
To view Cynvec’s complete investors history, request access »

Ready to get started?

Request a free trial

Cynvec FAQs

  • When was Cynvec founded?

    Cynvec was founded in 2004.

  • Where is Cynvec headquartered?

    Cynvec is headquartered in New York, NY.

  • What is the size of Cynvec?

    Cynvec has 3 total employees.

  • What industry is Cynvec in?

    Cynvec’s primary industry is Drug Discovery.

  • Is Cynvec a private or public company?

    Cynvec is a Private company.

  • What is Cynvec’s current revenue?

    The current revenue for Cynvec is .

  • How much funding has Cynvec raised over time?

    Cynvec has raised $7.4M.

  • Who are Cynvec’s investors?

    National Institutes of Health, National Cancer Institute, Alexander 2006, and The Litwin Foundation have invested in Cynvec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »